Acta Scientific Gastrointestinal Disorders

Editorial Volume 8 Issue 5

Cumulative and Big C-Adenocarcinoma Epididymis

Anubha Bajaj*

Department of Histopathology, Panjab University/A.B. Diagnostics, India

*Corresponding Author: Anubha Bajaj, Department of Histopathology, Panjab University/A.B. Diagnostics, India.

Received: April 01, 2025; Published:April 02, 2025

Abstract

Adenocarcinoma epididymis emerges as an extremely exceptional, de novo neoplasm confined to the epididymis. Tumefaction is additionally designated as papillary adenocarcinoma, cystadenocarcinoma or papillary cystadenocarcinoma. Adenocarcinoma epididymis demonstrates mean age of disease emergence at 67 years with neoplastic appearance between 27 years to 82 years.

References

  1. Xiao J., et al. “Treatment of primary epididymal adenocarcinoma: a case report and review of the literature”. Journal of Medical Case Reports 1 (2024): 274.
  2. Sun Q., et al. “Primary adenocarcinoma of the spermatic cord: a case report and review of the literature”. Diagnostic Pathology 1 (2024): 136.
  3. Wang KY., et al. “Rare epididymal-derived myoepithelial carcinoma: a case report and review of literature”. Annals of Clinical and Laboratory Science 50.3 (2020): 391-396.
  4. Li Q., et al. “One case of primary epididymal adenosquamous cell carcinoma with multiple metastases”. Journal of Clinical Urology 35.5 (2020): 421-422.
  5. Gao LJ., et al. “Primary epididymis malignant triton tumor: case report and review of the literature”. European Journal of Medical Research 20.1 (2015): 79.
  6. Suh JY., et al. “Primary malignant B-cell lymphoma of the epididymis”. Urology Case Reports 4 (2015): 27-29.
  7. Jing JG., et al. “Ultrasound diagnosis of 5 cases of primary malignant tumors of the epididymis”. Acoustic Technology 34.4 (2015): 282-286.
  8. Image 1 Courtesy: Libre Pathology.
  9. Image 2 Courtesy: Wikimedia commons.

Citation

Citation: Anubha Bajaj. “Cumulative and Big C-Adenocarcinoma Epididymis".Acta Scientific Gastrointestinal Disorders 8.5 (2025): 01-02.

Copyright

Copyright: © 2025 Anubha Bajaj. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.

Contact US